Influenza Viruses -Advance in Detection & Differentiation

Influenza outbreaks and epidemics constitute ongoing risks to global human public health. Recently, human infections with A/H5N1 avian influenza viruses have intensified the potential for the emergence of an influenza A virus with pandemic potential. Laboratory identification of human influenza virus infections is commonly performed using virus isolation in cell culture, direct antigen detection, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR). In recent years commercial influenza rapid diagnostic tests have become available which are antigen detection tests that produce results within 30 minutes. They can provide results in a clinically relevant time frame to complement the use of antiviral medications for treatment and chemoprophylaxis of Influenza

  • Biomarkers for influenza
  • Assays and symptoms
  • Strain identification assays and rapid diagnostic testing for viral infections
  • Rapid detection methods by PCR

Related Conference of Influenza Viruses -Advance in Detection & Differentiation

Influenza Viruses -Advance in Detection & Differentiation Conference Speakers